Dicerna Pharmaceuticals Names John "Jack" Green Interim CFO

Loading...
Loading...
Dicerna Pharmaceuticals, Inc.
DRNA
today announced the appointment of John "Jack" Green as interim chief financial officer (CFO), effective January 1, 2016. He replaces James Dentzer, whose departure is also announced today. Mr. Green is a Certified Public Accountant with over 30 years of financial management experience, including more than 20 years within the biotechnology industry. Concurrently to serving as part-time, interim CFO at Dicerna, Mr. Green will continue in a part-time capacity as CFO of Verastem, Inc. (VSTM). Previously, he served for more than 15 years as CFO of GTC Biotherapeutics (formerly Genzyme Transgenics), a publicly traded biotech company spun out of Genzyme as a
See full press release
Posted In: NewsManagementPress Releases
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...